HTAi 2024 Asia Policy Forum
Mark your calendars for a groundbreaking event in the world of Health Technology Assessment (HTA) as...
November 6 - November 8Access Forum : Addressing Challenges Impacting Patient Access
Join us for the 2nd annual ACCESS EU conference in Barcelona, Spain, themed “Addressing Challenges...
November 14 - November 16ISPOR Europe 2024
Now is the opportunity to connect with worldwide healthcare leaders who share your passion for Healt...
November 17 - November 207th Health Economics Congress
The Health Economics and Policy Association (Sağlık Ekonomisi ve Politikası Derneği – SEPD...
December 12-08:00 - December 13-17:00World EPA Congress 2025
The World Evidence, Pricing and Access (EPA) Congress is set to take center stage as Europe’s ...
March 5, 2025 - March 6, 2025
Events & Webinars
GSK and ViiV Healthcare to Showcase Breakthroughs in Infectious Disease at IDWeek 2024
Key TakeawaysGSK and ViiV Healthcare will present 60 abstracts at IDWeek 2024, showcasing innovations in vaccines and therapeutics, including solutions for HIV, antimicrobial resistance, and RSV.
GSK's Arexvy...
G-BA
G-BA Updates Guidelines for Tremelimumab and Durvalumab in Advanced Hepatocellular Carcinoma Treatment
Key TakeawaysThe G-BA has revised its Arzneimittel-Richtlinie to improve the benefit assessment for Tremelimumab and Durvalumab as first-line treatment for hepatocellular carcinoma (HCC).
Patient estimates for eligibility have...
Key TakeawaysNIHR invests £27 million to boost mental health research in under-served regions, aiming to diversify study participants and improve treatment outcomes.
Hull and Bath universities are initial...
In a significant move on August 15, 2024, the Gemeinsamer Bundesausschuss (G-BA) updated its pharmaceutical guidelines, marking a pivotal development in the exchangeability of drugs. The G-BA's inclusion of...
Upcoming Meetings
Pharmacoeconomics
Latest NewsLatest
GSK and ViiV Healthcare to Showcase Breakthroughs in Infectious Disease at IDWeek 2024
Key TakeawaysGSK and ViiV Healthcare will present 60 abstracts at IDWeek 2024, showcasing innovations in vaccines and therapeutics, including solutions for HIV, antimicrobial...
CMS Releases 2025 Medicare Star Ratings to Drive Quality in Healthcare
Key TakeawaysThe 2025 Star Ratings for Medicare Advantage (MA) and Part D plans are now available, offering seniors a clear evaluation of healthcare...
NCAPR Meeting in Budapest Focuses on Donor Engagement and Healthcare Substance Safety
Key TakeawaysSubstances of Human Origin (SoHO): Strengthened regulations aim to enhance safety and quality across EU borders.
Pricing and Reimbursement Collaboration: Joint efforts...
AGENAS to Present PNE 2024 Report, Shaping Italy’s Healthcare Future
Key TakeawaysPNE 2024 serves as a vital tool for assessing hospital performance and improving patient care across Italy.
The event on October 29,...
G-BA Updates Medicines Directive for Bile Duct Disorders, Expands to Include Functional Dyspepsia
Key TakeawaysFunctional dyspepsia medications are now included in Germany’s Medicines Directive for bile duct disorders.
The removal of bile acid derivative exemptions reflects...
G-BA Updates Guidelines for Tremelimumab and Durvalumab in Advanced Hepatocellular Carcinoma Treatment
Key TakeawaysThe G-BA has revised its Arzneimittel-Richtlinie to improve the benefit assessment for Tremelimumab and Durvalumab as first-line treatment for hepatocellular carcinoma (HCC).
...
FDA Addresses Drug Shortages, Advances Antimicrobial and Breast Cancer Treatments
Key TakeawaysFDA combats drug shortages caused by Hurricane Helene, focusing on restoring critical IV solution supplies.
Antimicrobial sales for food-producing animals continue to...
G-BA Updates Drug Directive: New Amendments Impact Medicinal Product Validity
Key TakeawaysThe G-BA introduces amendments to its Drug Directive, affecting the naming and validity of medications with new active substances. These changes take...
Abbott Pushes Forward with New Milestones in Electrophysiology
Abbott is making significant strides in the field of electrophysiology with its latest advancements in pulsed field ablation (PFA) technologies, reflecting the company’s commitment...
G-BA Enhances Prescription Guidelines for Acidosetherapeutika in Kidney Care
The healthcare landscape in Germany witnessed a pivotal development as the Gemeinsamer Bundesausschuss (G-BA) took decisive steps to refine the prescription guidelines for Acidosetherapeutika....
